Dapaglifozin

Sharon Rees

doi:10.12968/jprp.2021.3.5.166

Dapaglifozin

Sharon Rees

Advanced Practice & Non Medical Prescribing

Research output: Contribution to journal › Article

Abstract

In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #dapagliflozin

Original language	English
Pages (from-to)	166-166
Journal	Journal of Prescribing Practice
DOIs	https://doi.org/10.12968/jprp.2021.3.5.166
Publication status	Published - 2 May 2021

Access to Document

10.12968/jprp.2021.3.5.166Licence: CC BY 4.0

Cite this

@article{ebfe9e78ded14d95be0783decc1209ea,

title = "Dapaglifozin",

abstract = "In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #dapagliflozin",

author = "Sharon Rees",

year = "2021",

month = may,

day = "2",

doi = "10.12968/jprp.2021.3.5.166",

language = "English",

pages = "166--166",

}

TY - JOUR

T1 - Dapaglifozin

AU - Rees, Sharon

PY - 2021/5/2

Y1 - 2021/5/2

N2 - In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #dapagliflozin

AB - In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #dapagliflozin

U2 - 10.12968/jprp.2021.3.5.166

DO - 10.12968/jprp.2021.3.5.166

M3 - Article

SN - 2631-8385

SP - 166

EP - 166

JO - Journal of Prescribing Practice

JF - Journal of Prescribing Practice

ER -

Dapaglifozin

Abstract

Access to Document

Other files and links

Fingerprint

Cite this